torbjorn moe eggboe_transfusions_norway
TRANSCRIPT
Torbjørn Eggebø N
ational Center
for Fetal Medicine
Dept O
b & G
yn Trondheim
- Norw
ay
Organisation of invasive fetal
medicine in N
orway
Deliveries
! 60 000 /year
! O
nly risk groups are offered 1 trimester
examination
" >38 years
! R
outine examination in second trim
ester
National center for fetal m
edicine – established 1990
1. N
ational responsibility for invasive procedures w
ith high risk for the fetus (e.g. transfusions) TTS
are referred abroad 2. C
enter of competence for fetal
medicine
NC
FM ! H
igh-risk prenatal invasive procedures like intrauterine transfusions and drainage of fetal effusions are centralized to the N
ational center for fetal medicine (N
SFM)
! The center is also a referral center for fetuses w
ith severe or unclear m
alformations
! A
ll invasive procedures and fetal malform
ations are recorded in a quality registry used for quality assurance and research
! N
CFM
teaches and trains midw
ives and doctors in ultrasound diagnostics
! In cooperation w
ith the Norw
egian University in Technology
(NTN
U), the center develops new
procedures and technologies in fetal m
edicine ! The center is a W
HO
collaborating center for diagnostic ultrasound in obstetrics and gynecology
1988: rhesus negative G
ravida 6, para 3, alive 1 Year
Delivery
Outcom
e o 1973
Vaginal delivery 2840 g, healthy (no anti-D
prophylaxis) o 1975
Vaginal delivery Stillbirth, erythroblastosis
o 1975 C
S N
eonatal death after 1 day o 1983
Miscarriage
o 1985 Ectopic pregnancy
� 1988
CS, 32 w
eeks 5 fetal transfusions; 1600 g
First fetal transfusion in Norw
ay
Etiology of fetal anemia in fetuses treated w
ith blood transfusions at N
CFM
from 1988 to 2007
1988–2007 N
= 101
Rhesus-D
69% Parvovirus
11%
Rhesus-E
2% K
ell 2%
Thalassemia 2%
H
emoglobinopathia 1%
CM
V 1%
Not know
n 12%
Anti-bodies
that may cause
fetal anemia
Anti-D
A
nti-c A
nti-E A
nti Kell
Anti Fy
a (Duffy) rarely (titer > 64)
Trondheim
94%
Anti-D
MC
A peak velocity in 111 fetuses at risk for anem
ia
16 20
24 28
32 36 w
eeks
MCA-PV (cm/sec)
90
50
40 30
20
10
60 70 80
100
1.50
median
Mari et al., N
Engl J Med 2000
MoM
A
nemia w
ith hydrops Δ A
nemia w
ithout hydrops o N
o anemia
Red cell alloim
munisation
Surveillance today
! O
bstetric history ! A
ntibody levels (titres) ! D
oppler of Arteria cerebri m
edia
! Fetal blood sam
pling and transfusion
MC
A P
V a
nd
EV
F
0
10
20
30
40
50
60
70
80
90
10
0
110
15
20
25
30
35
40
Ge
sta
tion
al a
ge
(we
ek
s)
MCA PV cm/secM
CA
PV
wh
en
EV
F <
25
MC
A P
V w
he
n E
VF
25
-34
MC
A P
V w
he
n E
VF
>3
4
Lin
ea
r (MC
A P
V w
he
n E
VF
<2
5)
Lin
ea
r (MC
A P
V w
he
n E
VF
25
-34
)
Lin
ea
r (MC
A P
V w
he
n E
VF
>3
4)
Correlation of M
CA
PV to EVF Trondheim
2000-2006 n= 66 n= 96 n=159
N=321
Median and 1.5 m
ultiples of the median
of MC
A during pregnancy M
ari et al.
Fetal blood sam
pling
Transfusion
MC
V PV and EVF before and after first transfusion Trondheim
N = 27
EVF before transfusion
EVF after transfusion
MC
V PV before transfusion
MC
V PV after transfusion
Invasive procedures (2008-14)
2008 2009
2010 2011
2012 2013
2014 A
nemia
7 (35) 3 (21)
2 (8) 2 (7)
7 (39) 6 (35)
5 (16)
March 2014
! R
hD - w
omen
! A
ntibodies in first trimester
! Free fetal D
NA
(RH
D) in w
eek 25 ! anti-D
imm
unoglobulin in week 29
(fetus+) ! Testing of child after delivery
2016
! Tw
o experienced doctors will
retire in Decem
ber 2015 ! O
ne of them w
ill still be available for invasive procedures
! Tw
o new doctors trained
Legal terminations
Wom
an decides up to 12+0 A
bortion council from 12-21+6
malform
ations social indications
From w
eek 22 it is not allowed
Exceptions – deadly m
alformations
maternal indications